
Regulators have given a new antibiotic the green light to treat urinary tract infections (UTIs) for the first time in almost three decades.
Gepotidacin, also known as Blujepa, can be used by women in the UK who suffer recurring infections, the Medicines and Healthcare products Regulatory Agency (MHRA) said.